Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Thymoglobulin to Prevent Chronic Graft Versus Host Disease in Patients Undergoing Hematopoietic Progenitor Cell Transplantation (HPCT) From Unrelated Donors

NCT01217723 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT01217723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Thymoglobulin to Prevent Chronic Graft Versus Host Disease in Patients Undergoing Hematopoietic Progenitor Cell Transplantation (HPCT) From Unrelated Donors
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2010
Completion date
January 31, 2014
Enrollment
198 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies